MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KÜHN, B.
Right arrow Articles by HEINRICH, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KÜHN, B.
Right arrow Articles by HEINRICH, P. C.

Molecular Pharmacology, Vol 19, 103-108, Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics

The Effect of D-Galactosamine and Actinomycin D on Polysomes and Messenger RNA Levels in Rat Liver

BARBARA KÜHN 1, ANGEL ALONSO 1, and PETER C. HEINRICH 1

1 Biochemisches Institut, Universität Freiburg, 7800 Freiburg in Breisgau, and Institut für Experimentelle Pathologie, Deutsches Krebsforschungszentrum, 6900 Heidelberg, Germany

The amount of polysomes isolated from rat liver 6 hr after D-galactosamine administration decreased to approximately 50% of that isolated from livers of control rats. This decrease was not found after the administration of actinomycin D, although RNA synthesis was inhibited to a similar extent. No corresponding decrease in total hepatic mRNA after D-galactosamine injection was found upon translation in vitro in a reticulocyte cell-free system. The albumin mRNA level measured either by translation in vitro and immunoprecipitation or by hybridization to a specific complementary DNA probe was also unchanged after D-galactosamine administration. It is concluded that the disaggregation of polysomes observed after D-galactosamine administration cannot be due to alterations in mRNA but may rather be due to the modification or loss of as yet unknown molecules involved in the binding of ribosomes to mRNA.

Note:
ACKNOWLEDGMENTS The authors would like to thank Prof. Dr. K. Decker and Prof. Dr. W. Reutter for their interest in this work, many helpful discussions, and the critical reading of the manuscript. We also thank H.-P. Henninger, Freiburg, for his help with the high-pressure liquid chromatography analysis.

Submitted on April 28, 1980
Accepted on August 26, 1980







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics